PTPN22 and squamous cell carcinoma: Using LyP-1 (a homing peptide for p32 receptortargeting) to guide NPs carrying endostatin can effectively deliverthe drug to specific sites to achieve strong antiangiogenic effectsin squamous cell carcinoma.